EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor

Term ID

CHEBI:77108

Synonyms

(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitor
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitors
11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors
15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitor
15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitors
15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitor
15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitors
15-hydroxyprostaglandin dehydrogenase inhibitor
15-hydroxyprostaglandin dehydrogenase inhibitors
15-hydroxyprostanoic dehydrogenase inhibitor
15-hydroxyprostanoic dehydrogenase inhibitors
15-OH-PGDH inhibitor
15-OH-PGDH inhibitors
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitors
EC 1.1.1.141 inhibitor
EC 1.1.1.141 inhibitors
NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitor
NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitors
NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitor
NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors
PGDH inhibitor
PGDH inhibitors
prostaglandin dehydrogenase inhibitor
prostaglandin dehydrogenase inhibitors

Definition

An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of 15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor

EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor Show first 5 Terms
inverse has_role: berberine CAY10397

berberine CAY10397 Show first 5 Terms

Phenotype

Phenotype resulting from EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor

Phenotype where environments contain EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor

Phenotype modified by environments containing EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor

Human Disease / Model Data